NTRB,Nutriband Inc. | Healthcare

Healthcare

NTRB

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Nutriband Inc.NTRB

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products.

Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.

The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.

It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology.

The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Latest News >

Resmed Insider Sold Shares Worth $484,220, According to a Recent SEC Filing

Feb 5, 2025

04:51 PM EST, 02/05/2025 (MT Newswires) -- Peter C Farrell, Director, on February 05, 2025, sold 2,000 shares in Resmed ( RMD ) for $484,220. Following the Form 4 filing with the SEC, Farrell has control over a total of 77,218 common shares of the company, with 77,218 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943819/000112760225003232/xslF345X05/form4.xml ...

Mid-America Apartment Communities Q4 Core AFFO Declines, Revenue Rises; 2025 Core AFFO Guidance Issued

Feb 5, 2025

04:52 PM EST, 02/05/2025 (MT Newswires) -- Mid-America Apartment Communities ( MAA ) reported late Wednesday Q4 core adjusted funds from operations of $2.03 per diluted share, down from $2.10 a year earlier. Analysts polled by FactSet expected adjusted FFO of $2.03. Rental and other property revenue for the quarter ended Dec. 31 was $549.8 million, up from $542.2 million...

TotalEnergies CEO doubles down on US LNG, downplays Trump tariff fears

Feb 5, 2025

* Plans to expand Cameron, Rio Grande projects over next decade * CEO says Trump will be pragmatic * Company LNG portfolio can handle trade disruptions * Urges Europe not to ban Russian LNG before 2027 By America Hernandez LONDON, Feb 5 (Reuters) - TotalEnergies will expand its investment in U.S. liquefied natural gas over the next decade as the...

Murphy USA Q4 Earnings, Revenue Fall; Shares Down After Hours

Feb 5, 2025

04:52 PM EST, 02/05/2025 (MT Newswires) -- Murphy USA ( MUSA ) reported Q4 earnings late Wednesday of $6.96 per diluted share, down from $7 a year earlier. Two analysts polled by FactSet expected $6.67. Operating revenue for the quarter ended Dec. 31 fell to $4.71 billion from $5.07 billion a year earlier. Analysts surveyed by FactSet expected $4.90 billion....